Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ORITAVANCIN DIPHOSPHATE vs OSPHENA: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ORITAVANCIN DIPHOSPHATE vs OSPHENA: Safety Overview

Metric	ORITAVANCIN DIPHOSPHATE	OSPHENA
Total FAERS Reports	276	205
Deaths Reported	4	0
Death Rate	1.4%	N/A
Hospitalizations	27	4
Average Patient Age	58.5 yrs	60.0 yrs
% Female Patients	39.2%	N/A
FDA Approval Date	Aug 6, 2014	N/A
Manufacturer	Melinta Therapeutics, LLC	N/A
Route	INTRAVENOUS	N/A
Marketing Status	Prescription	N/A